| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 11.05. | CPTx Adds Edward Rebar as CSO, Promotes David Maier to CBO | ||
| 11.05. | VIVEbiotech Adds EvoLVcell to Its Catalogue of LVV-Manufacturing Products | ||
| 11.05. | Charles River Laboratories Introduces AI-Powered, End-to-End Workflow | ||
| 11.05. | AGC Biologics Joins OXTL's Clinical Development Network as a Manufacturing Partner | ||
| 11.05. | Lilly to Invest an Additional $4.5B Across Two Indiana Sites | ||
| 08.05. | LenioBio and Twist Bioscience Partnering on AI Drug Discovery Models | ||
| 08.05. | Traws Pharma to Advance Potential Hantavirus Treatment Clinical Candidates | ||
| 08.05. | BMS Gets EU Approval for Sotyktu for Treatment of Active Psoriatic Arthritis | ||
| 08.05. | Harbour BioMed's IND for HBM7004 Cleared by FDA | ||
| 07.05. | Blackstone Life Sciences Invests $250M in Anagram Therapeutics for Pancreatic Enzyme Replacement Therapy | ||
| 07.05. | Carbogen Amcis Shanghai Site Successfully Completes Unannounced NMPA GMP Inspection | ||
| 07.05. | Adragos Pharma Appoints Konstantinos Rengis as CEO | ||
| 07.05. | Altasciences, Certara Partner to Accelerate Early-Phase Drug Development | ||
| 07.05. | GSK Licenses Halozyme ENHANZE for Subcutaneous Cancer Drugs | ||
| 07.05. | TORL Appoints Aran Maree as CEO | ||
| 07.05. | Roche Enters Merger Agreement to Acquire PathAI for $750M Upfront | ||
| 07.05. | Hovione, IDC Launch Intranasal Drug Delivery Platform | ||
| 07.05. | BMS Licenses SYNtecan Linker-Payload Platform from Lonza | ||
| 07.05. | GSK Bets on ALK7-Targeting siRNA SA030 in New SiranBio Partnership | ||
| 06.05. | Tissue Dynamics, Galmed Pharmaceuticals to Develop Human Chronic Cardiac Fibrosis Model | ||
| 06.05. | Neuland, LIR Life Partner to Advance Cell Penetrating Peptide Platform | ||
| 06.05. | SK pharmteco Greenhouse Gas Emission Reduction Targets Validated by SBTi | ||
| 06.05. | FUJIFILM Biosciences and NextCell Launch Global Research-Use Stromal Cell Platform | ||
| 06.05. | Halozyme Agrees to License Hypercon Technology to Oruka to Develop Psoriasis Treatment | ||
| 06.05. | Symeres Taps Henning Steinhagen as CEO |